Logo image of DLX.DE

DELIGNIT AG (DLX.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DLX - DE000A0MZ4B0 - Common Stock

2.18 EUR
-0.02 (-0.91%)
Last: 12/9/2025, 7:00:00 PM
Fundamental Rating

5

DLX gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 12 industry peers in the Paper & Forest Products industry. DLX has only an average score on both its financial health and profitability. DLX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

DLX had positive earnings in the past year.
DLX had positive earnings in each of the past 5 years.
Of the past 5 years DLX 4 years had a positive operating cash flow.
DLX.DE Yearly Net Income VS EBIT VS OCF VS FCFDLX.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M 6M

1.2 Ratios

The Return On Assets of DLX (1.77%) is comparable to the rest of the industry.
DLX has a Return On Equity (2.33%) which is in line with its industry peers.
DLX's Return On Invested Capital of 2.11% is on the low side compared to the rest of the industry. DLX is outperformed by 66.67% of its industry peers.
DLX had an Average Return On Invested Capital over the past 3 years of 6.49%. This is in line with the industry average of 5.21%.
The last Return On Invested Capital (2.11%) for DLX is well below the 3 year average (6.49%), which needs to be investigated, but indicates that DLX had better years and this may not be a problem.
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROIC 2.11%
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
DLX.DE Yearly ROA, ROE, ROICDLX.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

DLX's Profit Margin of 1.39% is in line compared to the rest of the industry. DLX outperforms 41.67% of its industry peers.
In the last couple of years the Profit Margin of DLX has declined.
DLX's Operating Margin of 1.99% is on the low side compared to the rest of the industry. DLX is outperformed by 75.00% of its industry peers.
DLX's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 43.73%, DLX is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Gross Margin of DLX has grown nicely.
Industry RankSector Rank
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
DLX.DE Yearly Profit, Operating, Gross MarginsDLX.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so DLX is destroying value.
The number of shares outstanding for DLX remains at a similar level compared to 1 year ago.
DLX has more shares outstanding than it did 5 years ago.
DLX has a better debt/assets ratio than last year.
DLX.DE Yearly Shares OutstandingDLX.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
DLX.DE Yearly Total Debt VS Total AssetsDLX.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

DLX has an Altman-Z score of 3.87. This indicates that DLX is financially healthy and has little risk of bankruptcy at the moment.
DLX has a Altman-Z score of 3.87. This is amongst the best in the industry. DLX outperforms 91.67% of its industry peers.
DLX has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.03, DLX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.87
ROIC/WACC0.29
WACC7.25%
DLX.DE Yearly LT Debt VS Equity VS FCFDLX.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

DLX has a Current Ratio of 4.14. This indicates that DLX is financially healthy and has no problem in meeting its short term obligations.
DLX's Current ratio of 4.14 is amongst the best of the industry. DLX outperforms 100.00% of its industry peers.
DLX has a Quick Ratio of 1.86. This is a normal value and indicates that DLX is financially healthy and should not expect problems in meeting its short term obligations.
DLX's Quick ratio of 1.86 is amongst the best of the industry. DLX outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 4.14
Quick Ratio 1.86
DLX.DE Yearly Current Assets VS Current LiabilitesDLX.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

DLX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.89%.
Measured over the past years, DLX shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.22% on average per year.
The Revenue for DLX has decreased by -16.67% in the past year. This is quite bad
Measured over the past years, DLX shows a small growth in Revenue. The Revenue has been growing by 0.24% on average per year.
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%

3.2 Future

DLX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.22% yearly.
Based on estimates for the next years, DLX will show a quite strong growth in Revenue. The Revenue will grow by 8.13% on average per year.
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y8.13%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DLX.DE Yearly Revenue VS EstimatesDLX.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 20M 40M 60M 80M 100M
DLX.DE Yearly EPS VS EstimatesDLX.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 27.25 indicates a quite expensive valuation of DLX.
DLX's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 26.29. DLX is around the same levels.
Based on the Price/Forward Earnings ratio of 7.99, the valuation of DLX can be described as very cheap.
Based on the Price/Forward Earnings ratio, DLX is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
DLX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.51.
Industry RankSector Rank
PE 27.25
Fwd PE 7.99
DLX.DE Price Earnings VS Forward Price EarningsDLX.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DLX indicates a rather cheap valuation: DLX is cheaper than 83.33% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.42
DLX.DE Per share dataDLX.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

DLX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
DLX's earnings are expected to grow with 44.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%

4

5. Dividend

5.1 Amount

DLX has a Yearly Dividend Yield of 2.34%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 4.25, DLX has a dividend in line with its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, DLX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.34%

5.2 History

The dividend of DLX is nicely growing with an annual growth rate of 11.75%!
Dividend Growth(5Y)11.75%
Div Incr Years0
Div Non Decr Years0
DLX.DE Yearly Dividends per shareDLX.DE Yearly Dividends per shareYearly Dividends per share 2019 2021 2023 2024 2025 0.02 0.04 0.06 0.08

5.3 Sustainability

DLX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y56.67%
EPS Next 3Y44.23%
DLX.DE Yearly Income VS Free CF VS DividendDLX.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M

DELIGNIT AG

FRA:DLX (12/9/2025, 7:00:00 PM)

2.18

-0.02 (-0.91%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)08-26 2025-08-26
Earnings (Next)04-27 2026-04-27/amc
Inst Owners69.27%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap22.32M
Revenue(TTM)62.14M
Net Income(TTM)863.00K
Analysts84
Price Target6.12 (180.73%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.34%
Yearly Dividend0.08
Dividend Growth(5Y)11.75%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-33.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.76%
Valuation
Industry RankSector Rank
PE 27.25
Fwd PE 7.99
P/S 0.36
P/FCF N/A
P/OCF N/A
P/B 0.6
P/tB 0.65
EV/EBITDA 4.42
EPS(TTM)0.08
EY3.67%
EPS(NY)0.27
Fwd EY12.51%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.07
BVpS3.62
TBVpS3.34
PEG (NY)1
PEG (5Y)N/A
Graham Number2.55
Profitability
Industry RankSector Rank
ROA 1.77%
ROE 2.33%
ROCE 2.98%
ROIC 2.11%
ROICexc 2.64%
ROICexgc 2.9%
OM 1.99%
PM (TTM) 1.39%
GM 43.73%
FCFM N/A
ROA(3y)5.21%
ROA(5y)5.41%
ROE(3y)7.38%
ROE(5y)8.31%
ROIC(3y)6.49%
ROIC(5y)7.02%
ROICexc(3y)7.91%
ROICexc(5y)8.19%
ROICexgc(3y)8.82%
ROICexgc(5y)9.23%
ROCE(3y)9.19%
ROCE(5y)9.93%
ROICexgc growth 3Y-25.04%
ROICexgc growth 5Y-10.87%
ROICexc growth 3Y-24.73%
ROICexc growth 5Y-10.11%
OM growth 3Y-21.75%
OM growth 5Y-7.53%
PM growth 3Y-20.84%
PM growth 5Y-4.84%
GM growth 3Y1.28%
GM growth 5Y2.22%
F-ScoreN/A
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.32
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.14
Quick Ratio 1.86
Altman-Z 3.87
F-ScoreN/A
WACC7.25%
ROIC/WACC0.29
Cap/Depr(3y)125.11%
Cap/Depr(5y)92.99%
Cap/Sales(3y)3.97%
Cap/Sales(5y)3.03%
Profit Quality(3y)140.65%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.89%
EPS 3Y-24.93%
EPS 5Y-7.22%
EPS Q2Q%-33.33%
EPS Next Y27.27%
EPS Next 2Y56.67%
EPS Next 3Y44.23%
EPS Next 5Y41.22%
Revenue 1Y (TTM)-16.67%
Revenue growth 3Y-1.58%
Revenue growth 5Y0.24%
Sales Q2Q%-8.15%
Revenue Next Year1.47%
Revenue Next 2Y7.57%
Revenue Next 3Y8.48%
Revenue Next 5Y8.13%
EBIT growth 1Y-53.75%
EBIT growth 3Y-22.99%
EBIT growth 5Y-7.31%
EBIT Next Year160%
EBIT Next 3Y71%
EBIT Next 5Y54.93%
FCF growth 1Y-37.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.76%
OCF growth 3YN/A
OCF growth 5Y21.67%

DELIGNIT AG / DLX.DE FAQ

What is the fundamental rating for DLX stock?

ChartMill assigns a fundamental rating of 5 / 10 to DLX.DE.


What is the valuation status for DLX stock?

ChartMill assigns a valuation rating of 5 / 10 to DELIGNIT AG (DLX.DE). This can be considered as Fairly Valued.


Can you provide the profitability details for DELIGNIT AG?

DELIGNIT AG (DLX.DE) has a profitability rating of 4 / 10.


Can you provide the financial health for DLX stock?

The financial health rating of DELIGNIT AG (DLX.DE) is 6 / 10.